scispace - formally typeset
N

Nobuaki Ozaki

Researcher at Nagoya University

Publications -  64
Citations -  2907

Nobuaki Ozaki is an academic researcher from Nagoya University. The author has contributed to research in topics: Insulin & Insulin resistance. The author has an hindex of 27, co-authored 64 publications receiving 2697 citations. Previous affiliations of Nobuaki Ozaki include Chiba University.

Papers
More filters
Journal ArticleDOI

cAMP-GEFII is a direct target of cAMP in regulated exocytosis.

TL;DR: In this article, it was shown that cAMP-GEFII, a cAMP sensor, binds to Rim (Rab3-interacting molecule, Rab3 being a small G protein) and to a new isoform, Rim2, both of which are putative regulators of fusion of vesicles to the plasma membrane.
Journal ArticleDOI

Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion.

TL;DR: Results indicate that the PKA-independent mechanism involving the cAMP-GEFII·Rim2 pathway is critical in the potentiation of insulin secretion by incretins.
Journal ArticleDOI

Regulation of Ca2+ channel expression at the cell surface by the small G-protein kir/Gem.

TL;DR: It is reported here that the GTP-bound form of kir/Gem, identified originally as a Ras-related small G-protein that binds CaM, inhibits high-voltage-activated Ca2+ channel activities by interacting directly with the β-subunit.
Journal ArticleDOI

Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice

TL;DR: Findings indicate that exendin-4 ameliorates the severity of DPN, which may be achieved by its direct actions on DRG neurons and their axons.
Journal ArticleDOI

Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences

TL;DR: The effect of this unique property of telmisartan on insulin resistance and circulating levels of adiponectin and highly sensitive C-reactive protein in hypertensive patients with type 2 diabetes is studied.